|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Available-for-sale fixed maturity securities, at fair value (net of allowance for credit losses of $0 and $3, respectively; amortized cost of $61,429 and $56,854, respectively) | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total available-for-sale fixed maturity securities, at fair value (net of allowance for credit losses of $0 and $3, respectively; amortized cost of $61,429 and $56,854, respectively) | ||||||||||||||||||||
| Mortgage loans on real estate (net of allowance for credit losses of $42,013 as of 2024 and $38,135 as of 2023) | ||||||||||||||||||||
| Mortgage loans on real estate, net of allowance | ||||||||||||||||||||
| Private loans, net of allowance | ||||||||||||||||||||
| Private loans, net of allowance | ||||||||||||||||||||
| Total mortgage loans on real estate (net of allowance for credit losses of $42,013 as of 2024 and $38,135 as of 2023) | ||||||||||||||||||||
| Real estate investments related to consolidated variable interest entities | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total equity securities, at fair value | ||||||||||||||||||||
| Mortgage loans on real estate and Private loans, at amortized cost | ||||||||||||||||||||
| Mortgage loans on real estate, net of allowance | ||||||||||||||||||||
| Private loans, net of allowance | ||||||||||||||||||||
| Private loans, net of allowance | ||||||||||||||||||||
| Investment real estate and real estate partnerships (net of accumulated depreciation of $218 and $228, respectively) | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total investment real estate and real estate partnerships (net of accumulated depreciation of $218 and $228, respectively) | ||||||||||||||||||||
| Limited partnerships and limited liability companies (2024 and 2023 include $501,084 and $506,685 related to consolidated variable interest entities) | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total limited partnerships and limited liability companies (2024 and 2023 include $501,084 and $506,685 related to consolidated variable interest entities) | ||||||||||||||||||||
| Derivative instruments | ||||||||||||||||||||
| Investment funds | ||||||||||||||||||||
| Policy loans | ||||||||||||||||||||
| Short-term investments, at estimated fair value | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total short-term investments, at estimated fair value | ||||||||||||||||||||
| Other invested assets | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total other invested assets | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Accrued investment income | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total accrued investment income | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Deferred sales inducements | ||||||||||||||||||||
| Deferred policy acquisition costs, deferred sales inducements and value of business acquired | ||||||||||||||||||||
| Premiums due and other receivables | ||||||||||||||||||||
| Ceded unearned premiums | ||||||||||||||||||||
| Deferred tax asset | ||||||||||||||||||||
| Income taxes recoverable | ||||||||||||||||||||
| Reinsurance recoverables and deposit assets | ||||||||||||||||||||
| Market risk benefits | ||||||||||||||||||||
| Property and equipment (net of accumulated depreciation of $129 and $352, respectively) | ||||||||||||||||||||
| Intangible assets (net of accumulated amortization of $324 and $154, respectively) | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total other assets | ||||||||||||||||||||
| Separate account assets | ||||||||||||||||||||
| Assets related to discontinued operations | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Policy benefit reserves | ||||||||||||||||||||
| Future policy benefits | ||||||||||||||||||||
| Policyholders’ account balances | ||||||||||||||||||||
| Policy and contract claims | ||||||||||||||||||||
| Market risk benefits | ||||||||||||||||||||
| Other policy funds and contract claims | ||||||||||||||||||||
| Notes and loan payable | ||||||||||||||||||||
| Subordinated debentures | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Unearned premium reserve | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Other policyholder funds | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total notes payable | ||||||||||||||||||||
| Long term borrowings | ||||||||||||||||||||
| Funds withheld for reinsurance liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Total other liabilities | ||||||||||||||||||||
| Separate account liabilities | ||||||||||||||||||||
| Liabilities related to discontinued operations | ||||||||||||||||||||
| Variable Interest Entities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Debt Instrument, Convertible, Liquidation Preference, Per Share | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Preferred stock | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Common stock; par value $1 per share; 200,000,000 shares authorized; issued and outstanding: 2024 - 79,572,172 shares (excluding 30,614,343 treasury shares); 2023 - 79,337,818 shares (excluding 30,765,023 treasury shares) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income, net of taxes | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total stockholders' equity attributable to American Equity Investment Life Holding Company | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
